⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVCR News
NovoCure Limited Ordinary Shares
U.S. FDA Approves Novocure’s Optune Pax ® for the Treatment of Locally Advanced Pancreatic Cancer
businesswire.com
NVCR
Novacore to Acquire CP Insurance Associates, Expanding Financial Institution and Insurance Services Capabilities
prnewswire.com
NVCR
Taiho Oncology Appoints Peter Melnyk as President & Chief Executive Officer
businesswire.com
ATNM
NVCR
$7.87 Bn Glioblastoma Multiforme Treatment Market Forecast to 2033
globenewswire.com
NVCR
Peter Melnyk Joins Taiho Oncology as President & Chief Operating Officer
businesswire.com
NVCR
PFE
BMY
ATMP
Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
businesswire.com
NVCR
NovoCure Ltd (NVCR) Product Pipeline Analysis Report 2025 - ResearchAndMarkets.com
businesswire.com
NVCR
Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
businesswire.com
NVCR
Single Injection of JointStem Demonstrates Sustained Clinical Benefits Over Five Years
accessnewswire.com
NVCR
Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight
prnewswire.com
BNTX
NVCR
ONCO
AZN
MRK
MRUS